THE PENNANT GROUP, INC. Business Acquisition, Pro Forma Revenue
THE PENNANT GROUP, INC. (PNTG) reported Business Acquisition, Pro Forma Revenue of $119.07 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2022-11-07
- THE PENNANT GROUP, INC. business acquisition, pro forma revenue for the quarter ending 2022-09-30 was $119.07M, a 4.31% increase year-over-year.
- THE PENNANT GROUP, INC. business acquisition, pro forma revenue for the quarter ending 2021-09-30 was $114.15M, a 15.24% increase year-over-year.
- THE PENNANT GROUP, INC. business acquisition, pro forma revenue for the quarter ending 2020-12-31 was $133.14M, a 0.68% increase year-over-year.
- THE PENNANT GROUP, INC. business acquisition, pro forma revenue for the quarter ending 2020-09-30 was $99.06M, a 5.12% increase year-over-year.
- THE PENNANT GROUP, INC. business acquisition, pro forma revenue for fiscal 2020 was $424.81M, a 7.15% increase from fiscal 2019.
- THE PENNANT GROUP, INC. business acquisition, pro forma revenue for fiscal 2019 was $396.47M, a 25.81% increase from fiscal 2018.
- THE PENNANT GROUP, INC. business acquisition, pro forma revenue for fiscal 2018 was $315.13M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 3 month as first filed | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 9 month as first filed | Business Acquisition, Pro Forma Revenue 12 month | Business Acquisition, Pro Forma Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-09-30 | $119.07M 10-Q · filed 2022-11-07 | $352.25M 10-Q · filed 2022-11-07 | |||||
| 2021-09-30 | $114.15M 10-Q · filed 2022-11-07 | $334.61M 10-Q · filed 2022-11-07 | |||||
| 2020-12-31 | $133.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $232.20M derived: sum of 2 quarters · filed 2021-02-24 | $424.81M 10-K · filed 2021-02-24 | ||||
| 2020-09-30 | $99.06M 10-Q · filed 2020-11-10 | $291.66M 10-Q · filed 2020-11-10 | |||||
| 2019-12-31 | $132.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $226.49M derived: sum of 2 quarters · filed 2021-02-24 | $396.47M 10-K · filed 2021-02-24 | $349.88M 10-K · filed 2020-03-04 | |||
| 2019-09-30 | $94.23M 10-Q · filed 2020-11-10 | $88.80M 10-Q · filed 2019-11-12 | $264.22M 10-Q · filed 2020-11-10 | $260.39M 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | $82.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $162.82M derived: sum of 2 quarters · filed 2020-03-04 | $315.13M 10-K · filed 2020-03-04 | ||||
| 2018-09-30 | $80.22M 10-Q · filed 2019-11-12 | $232.52M 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |